Bijuva™ (estradiol/progesterone) – New drug approval
October 29, 2018 - TherapeuticsMD announced the FDA approval of Bijuva (estradiol/progesterone), for the treatment of moderate to severe vasomotor symptoms due to menopause in women with a uterus.
Download PDF
